It relates to topical dosage forms for topical application on skin for selective absorption by the skin tissue, particularly for administration of medicinal agents where a localized systemic application is desirable for medicines such as but not limited to glucosamine. In particular, it relates to pharmaceutical formulation of osteoarthritis drugs in the class of hexosamines or in combination of one or more nonnarcotic analgesics.